LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announced plans to offer broad, affordable, and streamlined access to Wegovy^® (semaglutide) through NovoCare^® Pharmacy. This integration offers a simplified pathway for cash-pay patients to access all FDA-approved dose strengths of Wegovy^® directly within LifeMD’s virtual care platform.